Get started
Bristol-Myers Squibb Co.Bristol-Myers Squibb Co.Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

BMYMP chart


Full chart

BMYMP upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪95.95 B‬ USD
Dividend yield (indicated)
5.26%
Price to earnings Ratio (TTM)
323.02
Basic EPS (TTM)
2.49 USD
Net income (FY)
‪−8.95 B‬ USD
Revenue (FY)
‪48.30 B‬ USD
Shares float
‪2.03 B‬
Beta (1Y)
0.29

Employees


Employees (FY)
‪34.1 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪1.42 M‬ USD
Net income / Employee (1Y)
‪−262.40 K‬ USD

About Bristol-Myers Squibb Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Christopher S. Boerner
Website
bms.com
Headquarters
Princeton
Founded
1933
ISIN
US1101222073
FIGI
BBG000002XP6
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMYMP.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BMYMP news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BMYMP highest yielding bonds


BMY5007343
Bristol-Myers Squibb Company 4.125% 15-JUN-2039
Yield to maturity
—
Maturity date
Jun 15, 2039
C
BMY3685700
Celgene Corporation 5.7% 15-OCT-2040
Yield to maturity
—
Maturity date
Oct 15, 2040
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
Yield to maturity
—
Maturity date
May 15, 2044
BMY5077466
Bristol-Myers Squibb Company 0.75% 13-NOV-2025
Yield to maturity
—
Maturity date
Nov 13, 2025
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
Yield to maturity
—
Maturity date
Aug 15, 2043
BMY5009254
Bristol-Myers Squibb Company 4.25% 26-OCT-2049
Yield to maturity
—
Maturity date
Oct 26, 2049
C
BMY4597873
Celgene Corporation 3.9% 20-FEB-2028
Yield to maturity
—
Maturity date
Feb 20, 2028
BMY5007346
Bristol-Myers Squibb Company 3.45% 15-NOV-2027
Yield to maturity
—
Maturity date
Nov 15, 2027
BMY5754772
Bristol-Myers Squibb Company FRN 20-FEB-2026
Yield to maturity
—
Maturity date
Feb 20, 2026
BMY3883364
Bristol-Myers Squibb Company 3.25% 01-AUG-2042
Yield to maturity
—
Maturity date
Aug 1, 2042
BMY4933148
Bristol-Myers Squibb Company 5.0% 15-AUG-2045
Yield to maturity
—
Maturity date
Aug 15, 2045

See all BMYMP bonds 

Sparks


Curated watchlists where BMYMP is featured.

See all sparks 

Frequently Asked Questions


The current price of BMYMP is 785.55 USD — it has decreased by −1.87% in the past 24 hours. Watch Bristol-Myers Squibb Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bristol-Myers Squibb Co. stocks are traded under the ticker BMYMP.
BMYMP stock has fallen by −1.93% compared to the previous week, the month change is a −0.42% fall, over the last year Bristol-Myers Squibb Co. has showed a −2.00% decrease.
BMYMP reached its all-time high on Nov 5, 2021 with the price of 2,000.00 USD, and its all-time low was 25.00 USD and was reached on Oct 4, 1974. View more price dynamics on BMYMP chart.
See other stocks reaching their highest and lowest prices.
BMYMP stock is 1.91% volatile and has beta coefficient of 0.29. Track Bristol-Myers Squibb Co. stock price on the chart and check out the list of the most volatile stocks — is Bristol-Myers Squibb Co. there?
Today Bristol-Myers Squibb Co. has the market capitalization of ‪95.95 B‬, it has increased by 0.08% over the last week.
Yes, you can track Bristol-Myers Squibb Co. financials in yearly and quarterly reports right on TradingView.
Bristol-Myers Squibb Co. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
BMYMP earnings for the last quarter are 1.46 USD per share, whereas the estimation was 1.09 USD resulting in a 33.79% surprise. The estimated earnings for the next quarter are 1.69 USD per share. See more details about Bristol-Myers Squibb Co. earnings.
Bristol-Myers Squibb Co. revenue for the last quarter amounts to ‪12.27 B‬ USD, despite the estimated figure of ‪11.44 B‬ USD. In the next quarter, revenue is expected to reach ‪11.76 B‬ USD.
BMYMP net income for the last quarter is ‪1.31 B‬ USD, while the quarter before that showed ‪2.46 B‬ USD of net income which accounts for −46.66% change. Track more Bristol-Myers Squibb Co. financial stats to get the full picture.
Yes, BMYMP dividends are paid quarterly. The last dividend per share was 0.50 USD. As of today, Dividend Yield (TTM)% is 5.22%. Tracking Bristol-Myers Squibb Co. dividends might help you take more informed decisions.
As of Sep 8, 2025, the company has ‪34.1 K‬ employees. See our rating of the largest employees — is Bristol-Myers Squibb Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bristol-Myers Squibb Co. EBITDA is ‪18.95 B‬ USD, and current EBITDA margin is 39.98%. See more stats in Bristol-Myers Squibb Co. financial statements.
Like other stocks, BMYMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bristol-Myers Squibb Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bristol-Myers Squibb Co. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bristol-Myers Squibb Co. stock shows the sell signal. See more of Bristol-Myers Squibb Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.